ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,631.22
      0.28%
      US Tech 100
      19,846.00
      0.00%
      Dow Jones
      40,211.72
      0.53%
      Brent Oil
      83.715
      -0.74%
      Bitcoin
      62,988.93
      -2.87%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. IDEAYA Biosciences Inc (IDYA)

      7. IDEAYA Biosciences Inc (IDYA) News

      IDYA

      IDEAYA Biosciences (IDYA)

      IDEAYA Biosciences Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:IDYA
      DateTimeSourceHeadlineSymbolCompany
      04/24/20234:12PMPR Newswire (US)IDEAYA Announces Proposed Public Offering of Common StockNASDAQ:IDYAIDEAYA Biosciences Inc
      04/23/20239:00AMPR Newswire (US)IDEAYA Announces Positive Interim Phase 2 Data for Darovasertib and Crizotinib Combination and Successful FDA Type C Meeting on Registrational Trial Design for Accelerated Approval in First-Line Metastatic Uveal MelanomaNASDAQ:IDYAIDEAYA Biosciences Inc
      04/19/20236:00AMPR Newswire (US)IDEAYA Announces First Patient Dosed in Phase 1 Clinical Trial for IDE161 as Potential First-in-Class PARG Inhibitor Targeting HRD Solid TumorsNASDAQ:IDYAIDEAYA Biosciences Inc
      04/14/20239:01AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:IDYAIDEAYA Biosciences Inc
      04/13/20234:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDYAIDEAYA Biosciences Inc
      04/03/20236:00AMPR Newswire (US)IDEAYA Biosciences to Participate in Upcoming April 2023 Investor Relations EventNASDAQ:IDYAIDEAYA Biosciences Inc
      03/31/20236:00AMPR Newswire (US)IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IDYAIDEAYA Biosciences Inc
      03/14/20234:31PMPR Newswire (US)IDEAYA Announces Presentations at AACR Annual Meeting 2023 for Potential First-in-Class Synthetic Lethality Programs IDE397 (MAT2A), IDE161 (PARG) and Werner HelicaseNASDAQ:IDYAIDEAYA Biosciences Inc
      03/13/20236:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDYAIDEAYA Biosciences Inc
      03/07/20234:56PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:IDYAIDEAYA Biosciences Inc
      03/07/20236:05AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDYAIDEAYA Biosciences Inc
      03/07/20236:00AMPR Newswire (US)IDEAYA Biosciences, Inc. Reports 2022 Financial Results and Provides Business UpdateNASDAQ:IDYAIDEAYA Biosciences Inc
      03/01/20236:00AMPR Newswire (US)IDEAYA Biosciences to Participate in Investor Conferences in March 2023NASDAQ:IDYAIDEAYA Biosciences Inc
      02/28/20235:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDYAIDEAYA Biosciences Inc
      02/27/20234:32PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:IDYAIDEAYA Biosciences Inc
      02/16/20236:00AMPR Newswire (US)IDEAYA Biosciences to Participate in Citi's 2023 Virtual Oncology Leadership SummitNASDAQ:IDYAIDEAYA Biosciences Inc
      02/14/20234:33PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IDYAIDEAYA Biosciences Inc
      02/14/20233:41PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IDYAIDEAYA Biosciences Inc
      02/14/20231:13PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IDYAIDEAYA Biosciences Inc
      02/14/202312:50PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IDYAIDEAYA Biosciences Inc
      02/14/202312:06PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IDYAIDEAYA Biosciences Inc
      02/14/202310:11AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IDYAIDEAYA Biosciences Inc
      02/09/202311:59AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IDYAIDEAYA Biosciences Inc
      02/01/202310:59AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IDYAIDEAYA Biosciences Inc
      02/01/20236:00AMPR Newswire (US)IDEAYA Biosciences to Participate in the 2023 Guggenheim Oncology ConferenceNASDAQ:IDYAIDEAYA Biosciences Inc
      01/23/20236:00AMPR Newswire (US)IDEAYA Announces Darovasertib Phase 2 Initiation in Neoadjuvant and Adjuvant Uveal Melanoma and Guidance for Clinical Data Update in Metastatic Uveal MelanomaNASDAQ:IDYAIDEAYA Biosciences Inc
      01/09/20236:00AMPR Newswire (US)IDEAYA Announces IND Clearance by U.S. FDA enabling Phase 1 Initiation for First-in-Class PARG Development Candidate IDE161NASDAQ:IDYAIDEAYA Biosciences Inc
      01/03/20236:00AMPR Newswire (US)IDEAYA Biosciences to Present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023NASDAQ:IDYAIDEAYA Biosciences Inc
      12/19/20226:00AMPR Newswire (US)IDEAYA Biosciences Appoints Dr. Karlene Cimprich, Ph.D. and Dr. Kornelia Polyak, M.D., Ph.D. to Scientific Advisory BoardNASDAQ:IDYAIDEAYA Biosciences Inc
      12/14/20224:34PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:IDYAIDEAYA Biosciences Inc
       Showing the most relevant articles for your search:NASDAQ:IDYA